Frontiers Multiple-Allele MHC Class II Epitope Engineering by a Molecular Dynamics-Based Evolution Protocol
Por um escritor misterioso
Descrição
Frontiers Multiple-Allele MHC Class II Epitope Engineering by a Molecular Dynamics-Based Evolution Protocol
High-resolution profiling of MHC II peptide presentation capacity reveals SARS-CoV-2 CD4 T cell targets and mechanisms of immune escape
High-resolution profiling of MHC II peptide presentation capacity reveals SARS-CoV-2 CD4 T cell targets and mechanisms of immune escape
Designing of a next generation multiepitope based vaccine (MEV) against SARS-COV-2: Immunoinformatics and in silico approaches
major histocompatibility complex class ii - List of Frontiers' open access articles
Toward Guided Mutagenesis: Gaussian Process Regression Predicts MHC Class II Antigen Mutant Binding
MHC Class II Binding Assays - ProImmune - Mastering Immunity _ MHC pentamers, CD1d tetramers, custom peptide synthesis, immunoassays, T cell epitope discovery, HLA tissue typing, cellular analysis, ligand binding assays, immune response
Frontiers Multiple-Allele MHC Class II Epitope Engineering by a Molecular Dynamics-Based Evolution Protocol
PANDORA v2.0: Benchmarking peptide-MHC II models and software improvements
Frontiers MHC Class II Polymorphisms, Autoreactive T-Cells, and Autoimmunity
Frontiers Design of a Recombinant Multivalent Epitope Vaccine Based on SARS-CoV-2 and Its Variants in Immunoinformatics Approaches
Rapid, Precise, and Reproducible Prediction of Peptide–MHC Binding Affinities from Molecular Dynamics That Correlate Well with Experiment
Frontiers Structure-Based Modeling of SARS-CoV-2 Peptide/HLA-A02 Antigens
Mutant MHC class II epitopes drive therapeutic immune responses to cancer
de
por adulto (o preço varia de acordo com o tamanho do grupo)